What Good Formulation Actually Costs

There’s a price floor beneath which quality isn’t possible. There’s also a price ceiling above which you’re paying for marketing, not product. Understanding the difference means knowing where skincare costs actually come from.

The £5 Serum Question

Here’s an uncomfortable truth: a £5 vitamin C serum cannot contain 15% L-ascorbic acid at pharmaceutical grade, properly stabilised, in airless packaging, with adequate preservation. The maths doesn’t work — the same maths that explains why serums cost more per ml than creams even though creams are often the more complex formulation.

Pharmaceutical-grade L-ascorbic acid costs roughly £80–150 per kilogram — and that’s the price large manufacturers pay buying in tonnes. Independent and small-batch brands, ordering at far lower volumes, routinely pay two to four times that, and stabilised derivative forms (ascorbyl glucoside, THD ascorbate, magnesium ascorbyl phosphate) cost more again. Even at the low end, 15% concentration in a 30ml serum works out to roughly £0.45 in the active alone — before stabiliser systems, antioxidant support, preservation, or packaging.

Then there’s VAT. UK retail prices include 20% VAT, so a £5 serum is actually £4.17 once HMRC’s cut is stripped out. That £4.17 has to cover the active, every supporting ingredient, the bottle, manufacturing, testing, compliance, distribution, retailer margin, and the brand’s own margin — with the vitamin C alone already eating a meaningful share of what’s left.

A £5 serum that claims to be a serious vitamin C treatment is either using lower-grade ingredients, a lower concentration, a less stable form, or some combination of all three. None of those are necessarily bad — but they’re different from what premium pricing buys.

Cheap isn’t impossible. But cheap and effective at the same level as properly formulated products? That’s fantasy economics.

Where The Money Actually Goes

The cost structure of a skincare product breaks down roughly like this:

Raw ingredients: 10–30% of production cost. This is where quality differentiation starts. Pharmaceutical-grade actives cost 2–10x more than cosmetic-grade equivalents. A brand committed to therapeutic concentrations is spending more here before anything else happens.

Formulation and stability testing: 5–15%. Getting ingredients to work together, stay stable, and deliver effectively costs money. This is R&D — and it’s where the years of development happen. A properly stabilised vitamin C formula requires months of testing. A “me too” formula copied from a contract manufacturer requires days.

Packaging: 15–40%. Here’s where it gets interesting. An airless pump that prevents oxidation costs significantly more than a jar with a lid. UV-protective glass costs more than clear plastic. The packaging that keeps your product effective often costs more than the packaging that looks impressive.

Manufacturing and filling: 10–20%. Scale matters enormously. A brand making 10,000 units pays more per unit than one making 500,000. Small batches preserve freshness but cost more. Large batches reduce cost but may sit in warehouses longer.

Testing and compliance: 5–10%. UK/EU cosmetic regulations require safety assessments, stability testing, and ongoing compliance. Brands cutting corners here are taking risks — legal and ethical ones.

Marketing and distribution: 30–60%. And here’s the variable that explains most price differences. A product that costs £3 to make might retail for £15 (direct-to-consumer, minimal marketing) or £80 (department store, celebrity endorsement, advertising spend). The product can be identical.

The Expensive Isn’t Always Better Trap

A £200 moisturiser isn’t automatically ten times better than a £20 one. Sometimes it’s the same core formula with a luxury tax attached — but not always, and the size of the gap matters more than people assume.

Some luxury moisturisers built around a “miracle” fermented-extract complex lean on the same core base — glycerin, mineral oil, petrolatum — as moisturisers costing a tenth of the price, with the proprietary complex doing little the base ingredients weren’t already doing. What high prices in cases like that buy: prettier packaging, celebrity associations, department store shelf space, magazine advertising, prestige positioning. What they don’t guarantee: better ingredients, higher concentrations, superior formulation, or improved results.

But that’s not the whole price ladder, and it’s a mistake to treat a £20–30 product and an £80+ product as interchangeable just because both sit above the £5 bargain-bin tier. A £25 serum using cosmetic-grade actives at workable-but-modest concentrations, filled by a contract manufacturer’s stock formula, is a genuinely different thing from an £85 serum built from scratch around pharmaceutical-grade actives, custom stability testing, and a delivery system designed for that specific formula. The second isn’t just “the same thing with better marketing” — bespoke formulation work costs real money in R&D, testing, and lower-volume ingredient sourcing that a stock formula never has to pay for.

That distinction matters most against the flood of white-label product on the market: thousands of brands buying an existing contract manufacturer’s template formula, changing the label, and selling it as if it were developed in-house. White label isn’t inherently bad — some template formulas are perfectly competent — but it is a different category of product from one genuinely formulated from scratch for a specific brief. Price alone won’t tell you which you’re looking at, but “developed from scratch” claims are worth checking for, because they’re the strongest single signal that you’re not buying a relabelled template.

None of this means expensive products are scams, or that mid-price products are lesser. Some products justify their price with genuinely superior formulation, rare ingredients, or small-batch quality control; some don’t. Expense alone tells you nothing about efficacy either way — the same logic applies to Korean and Japanese imports carrying a geography premium and to the “professional” ranges sold as inherently stronger than retail versions.

Where Quality Actually Lives

The quality sweet spot exists somewhere between “implausibly cheap” and “paying for luxury theatre.” Here’s what actually differentiates good formulation:

Ingredient sourcing. The same ingredient name can represent wildly different quality. Vitamin E from synthetic sources performs differently than vitamin E extracted from plant sources. Peptides from reputable manufacturers come with purity certificates and stability data; generic peptides may not. This quality difference doesn’t always show up on a label.

Concentration commitment. A brand that publishes its active percentages is making a verifiable claim. A brand that doesn’t could be at therapeutic levels or could be dusting. The willingness to be specific signals confidence — and invites accountability.

Stability investment. Unstable actives — vitamin C, retinol, certain peptides — require formulation work to remain effective over time. This means proper pH management, appropriate antioxidant systems, and packaging that protects contents. None of that is visible to you as a consumer, but it’s where serious formulation effort goes.

Delivery systems. Getting an ingredient onto your skin is easy. Getting it into the layers where it works is harder. Encapsulation, penetration enhancers, and vehicle formulation all affect whether actives reach their target. Some £15 products have better delivery than some £150 products — it’s about formulation knowledge, not price.

Honest shelf life. A product formulated for 24-month shelf life is making different choices than one formulated for 36 months. Shorter stability windows often indicate fresher formulation or less aggressive preservation. Neither is inherently better, but knowing the trade-off matters.

The Scale Problem

Large-scale manufacturing creates efficiencies, but it also creates compromises.

When you’re producing millions of units, you need ingredients that are consistently available in massive quantities. You need formulas that remain stable for years, not months. You need preservative systems that handle varied storage conditions across global supply chains. You need to minimise anything that might generate customer complaints at scale.

These constraints push toward safer, stabler, more universally tolerated formulations. That’s not bad — it’s just different from what’s possible at smaller scale.

A small brand making 5,000 units can use an ingredient that’s difficult to source at volume. They can accept a shorter shelf life. They can formulate for a specific skin concern without worrying about universal appeal. They can make choices that wouldn’t survive a corporate risk assessment.

The trade-off is convenience and cost. Small-batch production usually means higher prices. Limited ingredient access means products might be out of stock. Direct-to-consumer distribution means you’re not picking it up at Boots.

The Middle Ground

So what does good value in skincare actually look like?

Expect to pay more than budget, and don’t assume “more than budget” means one narrow band. For most active products — vitamin C serums, retinoids, exfoliating treatments — the £25–60 range is where template formulas at cosmetic-grade concentrations become realistic; £60–100+ is where genuinely bespoke, from-scratch formulation with pharmaceutical-grade actives becomes realistic. Below £25, ingredient compromises are likely. Above £100, scrutinise harder — some brands in that range are doing real bespoke R&D, others are relying on packaging and prestige to justify a white-label formula at a luxury price.

Simple products should be cheaper than complex ones. A basic moisturiser with glycerin and ceramides doesn’t require premium pricing. A stabilised vitamin C with peptides and sophisticated delivery systems legitimately costs more to produce. Price should correlate with formulation complexity.

Distribution model matters. A product sold direct-to-consumer can deliver more value at a given price than the same product sold through department stores. Retailers take 40–60% margins. That money comes from somewhere — either higher prices or lower product costs.

Look for unglamorous packaging. If a brand has spent their budget on heavy glass jars, custom moulded bottles, and elaborate outer packaging, they’ve spent less on what’s inside. The most effective packaging is often the least impressive-looking: airless pumps, aluminium tubes, simple bottles with pumps.

What To Actually Ask

When evaluating whether a product’s price reflects its quality, ask:

Does the brand disclose active percentages? If yes, are they at therapeutic levels? If no, why the secrecy?

What’s the primary distribution channel? Direct-to-consumer brands can offer better value at the same price point than retail brands.

Is the packaging functional or theatrical? Airless pumps cost more but preserve product integrity. Pretty jars look nice but expose contents to air and contamination.

Who owns the brand? Independent brands often have different cost structures — and different margin expectations — than conglomerate subsidiaries.

What’s the claimed shelf life? 24 months suggests different preservation choices than 36 months. Neither is wrong, but knowing tells you something about formulation priorities.

Next time a price tag surprises you either way, run it through the breakdown above: ingredients, formulation, packaging, manufacturing, marketing. Whichever line item is doing the heavy lifting tells you what you’re actually paying for.